跳至主要内容
临床试验/CTRI/2025/12/098962
CTRI/2025/12/098962尚未招募不适用

A randomised double blinded control trial between fentanyl and remifentanil in attenuating hemodynamic response to laryngoscopy and intubation in patients undergoing surgery under general anesthesia.

North Eastern Indira Gandhi Regional Institute of Health and Medical Sciences1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2026年1月1日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
40
试验地点
1
主要终点
which drug prevents increase in heart rate and blood pressure better

研究概览

简要总结

study hypothesis: Remifentanil is superior to fentanyl in blunting hemodynamic response to laryngoscopy and intubation during general anesthesia

This study aims to see if inj Remifentanil is superior to inj fentanyl in blunting hemodynamic stress response to laryngoscopy ad intubation

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Participant and Investigator Blinded

入排标准

年龄范围
18.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • Age- 18 to 65 years
  • ASA I,II and III
  • Both sexes
  • surgeries requiring General anesthesia with orotracheal intubation with direct laryngoscopy.

排除标准

  • pregnant and lactating women
  • previous sensitivity to fentanyl, remifentanil, propofol, egg or soya bean
  • patients on beta blockers
  • chronic use of alcohol, sedatives or opioid abuse.

结局指标

主要结局

which drug prevents increase in heart rate and blood pressure better

时间窗: At baseline and then at minute interval 1,3,5,10 and 15.

次要结局

  • side effects of the medications(at minute interval 5,15,30,60 post surgery till transfer out from recovery area.)

研究者

发起方
North Eastern Indira Gandhi Regional Institute of Health and Medical Sciences
申办方类型
Government medical college
责任方
Principal Investigator
主要研究者

Dr Newstar Syiemiong

North Eastern Indira Gandhi Regional Institute of Health and Medical Sciences

研究点 (1)

Loading locations...

相似试验